Dynamic Wealth Strategies’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.64K Hold
131
– – ﹤0.01% 287
2026
Q2
$3.31K Hold
131
– – ﹤0.01% 275
2026
Q1
$2.92K Hold
131
– – ﹤0.01% 262
2025
Q4
$3.5K Hold
131
– – ﹤0.01% 235
2025
Q3
$2.8K Hold
131
– – ﹤0.01% 228
2025
Q2
$2.83K Hold
131
– – ﹤0.01% 221
2025
Q1
$2.18K Buy
+131
New +$2.38K ﹤0.01% 223
2024
Q4
– Sell
-131
Closed -$2K – 68
2024
Q3
$2K Hold
131
– – ﹤0.01% 222
2024
Q2
$2K Hold
131
– – ﹤0.01% 229
2024
Q1
$2K Hold
131
– – ﹤0.01% 235
2023
Q4
$4.1K Buy
+131
New +$3.13K ﹤0.01% 228

Other funds holding ACAD

Dynamic Wealth Strategies's ACAD Position: Q3 2026 in Review

Dynamic Wealth Strategies held its Acadia Pharmaceuticals (ACAD) position steady in Q3 2026 at 131 shares worth $2.64K. The position accounts for ﹤0.01% of the portfolio, ranked #287.

Dynamic Wealth Strategies first reported a position in ACAD in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.1K in Q4 2023. 46 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

  • Dynamic Wealth Strategies held 131 shares of Acadia Pharmaceuticals worth $2.64K as of Q3 2026.
  • Dynamic Wealth Strategies left its Acadia Pharmaceuticals share count unchanged in Q3 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Dynamic Wealth Strategies's portfolio in Q3 2026, its #287 holding.
  • Dynamic Wealth Strategies first reported a position in Acadia Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Dynamic Wealth Strategies's Acadia Pharmaceuticals position peaked at $4.1K in Q4 2023.
  • 46 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on Dynamic Wealth Strategies's 13F filing for Q3 2026, filed 16 Oct 2026.